Andia JB. Aluminum toxicity: its relationship with bone and iron metabolism.
Nephrol Dial Transplant. 1996; 11 Suppl 3:69-73.
Bia MJ, Cooper K, et al. Aluminum induced anemia: pathogenesis and treatment in patients on chronic dialysis.
Kidney Int. 1989 Nov;36(5):852-8.
Delmez J, Weerts C, et al. Accelerated removal of deferoxamine mesylate-chelated aluminum by charcoal hyperfusion in hemodialysis patients.
Am J Kidney Disease. 1989 Apr;13(4):308-11.
D’Haese PC, Couttenye MM, et al. Use of the low-dose desferrioxamine test to diagnose and differentiate between patients with aluminum-related bone disease, increased risk for aluminum toxicity, or aluminium overload.
Nephrol dial Transplant. 1995;10:1874-84.
Goldman L, Ausiello D, eds.
Cecil Textbook of Internal Medicine. 23rd ed. Philadelphia, PA: Saunders; 2008.
Kawahara M. Effects of aluminum on the nervous system and its possible link with neurodegenerative diseases.
J Alzheimers Dis
Krewski D, Yokei RA, Nieboer E et al: Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide.
J Toxicol Environ Health b Crit Rev
. 2007:10 supl 1: 1-269
Malluche HH. Aluminum and bone disease in chronic renal failure.
Nephrol dial Transplant
. 2002; 17:21-24.
Marx JA, et al.
Rosen's Emergency Medicine
.7th ed. St. Louis, MO: Mosby, Inc.; 2009.
Molloy DW, Standish TI, Nieboer E et al: Effects of acute exposure to aluminum on cognition in humans.
J Toxicol Environ Health
. A 2007: 70:2011-9
Toxic substances portal: Aluminum. Centers for Disease Control and Prevention website. Available at:
. Updated October 27, 2011. Accessed April 2, 2013.
Agency for Toxic Substances and Disease Registry
Environmental Protection Agency
Guide to Less Toxic Products
Environmental Health Association of Nova Scotia
Poison Control Centers for Canada
Association of the Chemical Profession of Ontario